P.S Pharma And Healthcare India Private Limited
Founded in 2020 and headquartered in Maharashtra, India.
2020 | Nagpur, Maharashtra (India) | Active
P.S Pharma And Healthcare India Profile
Key Indicators
- Authorised Capital ₹ 0.10 M
- Paid Up Capital ₹ 0.10 M
- Company Age 5 Year, 21 Days
- Last Filing with ROC 31 Mar 2023
About P.S Pharma And Healthcare India
P.S Pharma And Healthcare India Private Limited (PPAHIPL) is a Private Limited Indian Non-Government Company incorporated in India on 06 February 2020 (Five years 21 days old ). Its registered office is in Nagpur, Maharashtra, India.
The Company is engaged in the Chemicals Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 0.10 M and a paid-up capital of Rs 0.10 M, as per Ministry of Corporate Affairs (MCA) records.
Shiv Singh and Priyanka Singh serve as directors at the Company.
Company Details
- Location
Nagpur, Maharashtra, India
- Telephone
+91-XXXXXXXXXX
- Email Address
- Website
-
- Social Media -
Corporate Identity Details
- CIN/LLPIN
U24110MH2020PTC337290
- Company No.
337290
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
06 Feb 2020
- Date of AGM
30 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Chemicals
Who are the key members and board of directors at P.S Pharma And Healthcare India?
Board Members (2)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Shiv Singh  | Director | 06-Feb-2020 | Current |
| Priyanka Singh | Director | 06-Feb-2020 | Current |
Financial Performance of P.S Pharma And Healthcare India.
Enhance accessibility to P.S Pharma And Healthcare India's financial data by unlocking access to both Standalone and Consolidated balance sheets, Profit & Loss Statements, Ratios, Related Party Transactions, and additional relevant information.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets | |||||||
| Profit or Loss | |||||||
| Net Worth | |||||||
| EBITDA |
What is the Ownership and Shareholding Structure of P.S Pharma And Healthcare India?
Unlock access to P.S Pharma And Healthcare India's control and ownership data, Corporate Shareholding Patterns, Funding (security allotment) details, Foreign Institutional Investor information, Directors and Key Management Personnel (KMP) Remuneration, Group Structure, Overseas Direct Investment and other pertinent data.
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at P.S Pharma And Healthcare India?
Unlock and access historical data on people associated with P.S Pharma And Healthcare India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of P.S Pharma And Healthcare India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped P.S Pharma And Healthcare India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.